The value of QT interval dispersion for identification of total mortality risk in non-insulin-dependent diabetes mellitus

Journal of Internal Medicine

Volumn 243, Issue 1, 1998, Pages 49-56

  Sawicki, P T ^a   Kiwitt, S ^a   Bender, R ^a   Berger, M ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Cardiac mortality; Cerebrovascular mortality; Non insulin dependent diabetes mellitus; QT interval; Risk factors; Total mortality

Indexed keywords

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; DIAGNOSTIC VALUE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QT INTERVAL; RISK ASSESSMENT;

AGED; CAUSE OF DEATH; CEREBROVASCULAR DISORDERS; DIABETES MELLITUS, TYPE 2; ELECTROCARDIOGRAPHY; FEMALE; GERMANY; HEART DISEASES; HEART RATE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK; TIME FACTORS;

EID: 0031929834     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1998.00259.x     Document Type: Article

References (43)

1. Kessler I. Mortality experience of diabetic patients. A twenty-six years follow-up study. Am J Med 1971; 51: 715-24.
2. Panzram G. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 123-31.
3. Morrish NJ, Stevens LK, Head J, Fuller JH, Jarrett RJ, Keen H. A prospective study of mortality among middle-aged diabetic patients (The London cohort of the WHO Multinational Study of Vascular Disease in Diabetics). Diabetologia 1990; 33: 538-41.
4. Moss SC, Klein R, Klein B. Cause-specific mortality in a population-based study of diabetes. Am J Publ Health 1991; 81: 1158-62.
5. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984; 310: 356-60.
6. The Hypertension in Diabetes Study Group. Hypertension in Diabetes Study (HDS): II. Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients. J Hypertens 1993; 11: 319-25.
7. Mühlhauser I. Cigarette smoking and diabetes: an update. Diabetic Medicine 1994; 11: 336-43.
8. Moss SE, Klein R, Klein BEK, Meuer SM. The association of glycemia and cause-specific mortality in a diabetic population. Arch Intern Med 1994; 154: 2473-9.
9. Gall MA, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving HH. Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes 1995; 44: 1303-9.
10. Heyden S, Heiss G, Bartel AG, Hammes CG. Sex differences in coronary mortality among diabetics in Evan's county, Georgia. J Chron Dis 1980; 33: 265-73.
11. Walters DP, Galting W, Houston AC, Mullee, Julious SA, Hill RD. Mortality in diabetic subjects: an eleven-year follow-up of a community-based population. Diabetic Medicine 1994; 11: 968-73.
12. Dekker JM, Schouten EG, Klootwijk P, Pool J, Kromhout D. Association between QT interval and coronary heart disease in middle-aged elderly men: the Zutphen study. Circulation 1994; 90: 779-85.
13. Glancy JM, Garratt CJ, Woods KL, de Bono DP. QT dispersion and mortality after myocardial infarction. Lancet 1995; 345: 945-8.
14. Barr CS, Naas A, Freeman M, Lang C, Struthers AD. QT dispersion and sudden unexpected death in chronic heart failure. Lancet 1994; 343: 327-9.
15. Buja G, Miorelli, Turrini P, Melacini P, Nava A. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death. Am J Cardiol 1993; 72: 973-6.
16. Darbar D, Luck J, Davidson N, Pringle T, Main G, McNeill G, et al. Sensitivity and specificity of QTc dispersion for identification of risk of cardiac death in patients with peripheral vascular disease. Br Med J 1996; 312: 874-9.
17. Day CP, James OFW, Butler TJ, Campbell RWF. QT prolongation and sudden cardiac death in patients with alcoholic liver disease. Lancet 1993; 341: 1423-8.
18. Bellavere F, Ferri M, Guarini L, Bax G, Piccoli A, Cardone C, et al. Prolonged QT period in diabetic autonomic neuropathy: a possible role in sudden cardiac death. Br Heart J 1988; 59: 379-83.
19. Ewing DJ, Boland O, Neilson JMM, Cho CG, Clarke BF. Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients. Diabetalogia 1991; 34: 182-5.
20. Jermendy G. Tóth L. Vörös P, Koltai MZ, Pogátsa G. Cardiac autonomic neuropathy and QT interval length. A follow-up study in diabetic patients. Acta Cardiol 1991; 46: 189-200.
21. Sawicki PT, Dähne R, Bender R, Berger M. Prolonged QT interval as a predictor of mortality in diabetic nephropathy. Diabetologia 1996; 39: 77-81.
22. Ewing DJ. Cardiac autonomic neuropathy. In: Jarrett, ed. Diabetes and Heart Disease. Elsevier, New York. 1984; 99-132.
23. Sawicki PT, Heinemann L, Berger M. Comparison of methods for determination of microalbuminuria in diabetic patients. Diabetic Medicine 1989; 6: 412-5.
24. Bland JM, Altman DG. Measurement Error. BMJ 1996; 312: 1654.
25. Healy MJR. Measuring measuring errors. Statistics in Medicine 1989; 8: 893-906.
26. Internationale Klassifikation der Krankheiten (ICD). 9. Revision. 2 Edition: Kohlhammer, Cologne, 1993.
27. Cox DR. Regression models and life tables (with discussion). J R Stat Soc B 1972; 34: 187-220.
28. SAS Institute. SAS/STAT Guide for Personal Computers. Version 6 ed. Cary, NC, SAS Institute Inc., USA, 1987.
29. SAS Institute. SAS Technical Report P-179, Additional SAS/STAT Procedures, Release 6.03. Cary, NC. SAS Institute Inc., USA, 1988.
30. SAS Institute. SAS Technical Report P-217, SAS/STAT Software. The PHREG Procedure. Version 6. Cary, NC, SAS Institute Inc., USA, 1991.
31. Schouten EG, Dekker JM, Meppelink P, Kok FJ, Vandenbroucke JP, Pool J. QT-interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation 1991; 84: 1516-23.
32. Dekker JM, Feskens EJM, Schouten EG, Klootwijk P, Pool J, Kromhout D. QTc duration is associated with levels of insulin and glucose tolerance. Diabetes 1996; 45: 376-80.
33. Shimabukuro M, Chibana T, Yoshida H, Nagamine F, Komiya I, Takasu N. Increased QT dispersion and cardiac adrenergic dysinnervation in diabetic patients with autonomic neuropathy. Am J Cardiol 1996; 78: 1057-9.
34. Turpeinen AK, Vanninen E, Kuikka JT, Uusitupa MIJ. Demonstration of regional sympathetic denervation of the heart in diabetes. Diabetes Care 1996; 19: 1083-90.
35. Towbin JA. New revelations about the long-QT syndrome. N Engl J Med 1995; 333: 384-5.
36. Kuo CS, Munakata K, Reddy P, Surawicz R. Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations. Circulation 1983; 67: 1356-67.
37. Zipes DP. The long QT interval syndrome. A rosetta stone for sympathetic related ventricular tachyarrythmias. Circulation 1991; 84: 1414-19.
38. Pye M, Cobbe SM. Mechanisms of ventricular arrythmias in cardiac failure and hypertrophy. Cardiavasc Res 1991; 26: 740-50.
39. Curb JD, Rodriguez BL, Burchfiel CM, Abbott RD, Chiu D, Yano K. Sudden death, impaired glucose tolerance and diabetes in Japanese American men. Circulation 1995; 91: 2591-5.
40. Goldberg R, Bengtson J, Chen Z, Anderson KM, Locati E, Levy D. Duration of the QT interval and total and cardiovascular mortality in healthy persons (The Framingham Heart Study Experience) Am J Cardiol 1991; 61: 55-8.
41. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
42. Goldner MG, Knatterud GL, Prout TE. Effects of hypoglycaemic agents on vascular complications in patients with adult-onset diabetes. JAMA 1971; 218: 1400-10.
43. Turner R, Cull C, Holman R, for the UKPDS Group. United Kingdom Prospective Diabetes Study 17: A 9-years update of a randomised, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med 1996; 124: 136-45.